Medicaid drugs.
The following commentary unites a collection of articles primarily concerned with prescription drug issues in Medicaid. It also features highlights from a piece outlining Australia's pharmaceutical delivery system. Specifically, in this issue, you will find comprehensive analyses of drug expenditure trends, issues regarding access to pharmaceuticals in Medicaid, and an evaluation of ongoing generic drug cost-containment programs.
Poisal
John A
JA
Centers for Medicare & Medicaid Services, 7500 Security Boulevard, C3-16-27, Baltimore, MD 21244-1850, USA. jpoisal@cms.hhs.gov
D003363:Cost Control; D016527:Drug Costs / Q000639:trends*; D006297:Health Services Accessibility; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D008484:Medicaid; D014481:United States